In studies of head and neck squamous cell carcinoma, increased Cldn1 expression has been associated with tumor progression through the inhibition of AMP-activated protein kinase activity and the activation of tumor growth factor-β signaling, which promotes tumor growth [48]. Here, CLDN1 is linked to head and neck squamous cell carcinoma.